US Patent Issued to Genomic Health on March 24 for "DNA methylation and mutational analysis methods for bladder cancer surveillance" (California Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,179, issued on March 24, was assigned to Genomic Health Inc. (Redwood City, Calif.).

"DNA methylation and mutational analysis methods for bladder cancer surveillance" was invented by Margarita Lopatin (Palo Alto, Calif.), Athanasios Tsiatis (San Francisco), Christopher N. Silk (Redwood City, Calif.), David P. Miller (Albany, Calif.), Michael R. Crager (Menlo Park, Calif.), Phillip Febbo (Mill Valley, Calif.) and Dejan Knezevic (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of monitoring bladder cancer patients and analyzing patient samples for presence of methylated DNA and optionally ...